◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksC › CPH

Cipher Pharmaceuticals Inc. (CPH) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-16

Cipher Pharmaceuticals Inc. (CPH) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mississauga, Canada. Its market capitalization is roughly $359 million. In the fiscal year ended 2025-12-31, CPH reported $50M in revenue and $27M in net income.

Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada.

Interactive charts & full statements →

CPH Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$50M$33M$21M$21M
Gross Profit$40M$24M$17M$17M
Operating Income (EBIT)$17M$8M$10M$11M
Net Income$27M$12M$20M$27M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CPH Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$12M$12M$13M$13M$12M
Gross Profit$10M$10M$10M$11M$9M
Operating Income (EBIT)$6M$4M$5M$5M$2M
Net Income$6M$13M$6M$6M$3M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CPH Free Cash Flow History

CPH Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$156M$162M$86M$74M
Total Liabilities$30M$60M$6M$10M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CPH viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← CPGAll “C” companiesCPHC →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.